🇺🇸 FDA
Patent

US 6818749

Variants of humanized anti carcinoma monoclonal antibody cc49

expired A61KA61K2039/505A61K38/00

Quick answer

US patent 6818749 (Variants of humanized anti carcinoma monoclonal antibody cc49) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Nov 11 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Nov 16 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 11 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
47
CPC classes
A61K, A61K2039/505, A61K38/00, A61K49/0002, A61K51/1045